Cerus Corporation (CERS)vsGE HealthCare Technologies Inc. (GEHC)
CERS
Cerus Corporation
$1.77
-2.75%
HEALTHCARE · Cap: $330.54M
GEHC
GE HealthCare Technologies Inc.
$72.20
+1.75%
HEALTHCARE · Cap: $32.38B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 9906% more annual revenue ($20.63B vs $206.13M). GEHC leads profitability with a 10.1% profit margin vs -7.6%. GEHC earns a higher WallStSmart Score of 60/100 (C+).
CERS
Avoid32
out of 100
Grade: F
GEHC
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CERS.
Margin of Safety
-156.0%
Fair Value
$30.94
Current Price
$72.20
$41.26 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
ROE of -25.7% — below average capital efficiency
Expensive relative to growth rate
Weak financial health signals
Earnings declined 17.7%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : CERS
Revenue growth of 13.7% demonstrates continued momentum.
Bull Case : GEHC
The strongest argument for GEHC centers on Return on Equity, P/E Ratio.
Bear Case : CERS
The primary concerns for CERS are EPS Growth, Market Cap, Debt/Equity. Debt-to-equity of 1.60 is elevated, increasing financial risk.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
CERS profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.
CERS carries more volatility with a beta of 1.53 — expect wider price swings.
CERS is growing revenue faster at 13.7% — sustainability is the question.
GEHC generates stronger free cash flow (917M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (60/100 vs 32/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cerus Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
Visit Website →GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?